Abstract

To the Editor.— Previous studies have established that methoxsalen (PUVA [methoxsalen plus ultraviolet light]) is an effective mode of treatment for psoriasis. 1 In a recent article inThe Journal, Stern et al (1981;245:1913) have demonstrated that this outpatient procedure is cost-effective for the treatment of psoriasis in view of the need for hospitalization for many such patients. This view was supported in an editorial by Henry H. Roenigk, MD, in the same issue (1981; 245:1941), who advocated Food and Drug Administration approval of labeling to recommend this procedure. However, the authors did not include in their equations the expenditures related to an already established risk of the treatment. Stern et al have demonstrated a significant increase in the skin cancer formation induced by this modality during a four-year period. 2,3 These cancers will require biopsies, histological examinations, and definitive therapy (eg, surgery, ionizing radiation) for complete eradication. The costs

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.